Biography
Regina is a pioneering leader in developing machine learning methods for drug discovery and clinical AI.Her groundbreaking work has produced AI models for early cancer detection and therapeutic discovery that have redefined what is possible in clinical diagnostics and biomedical innovation. At MITs Computer Science and Artificial Intelligence Laboratory and as AI Faculty Lead for the Jameel Clinic, she has advanced methods that detect breast and lung cancer earlier and more accurately, forecast adverse drug effects before human trials, and accelerate the design of novel therapeutics. Her research blends cutting-edge machine learning with a commitment to responsible integration of AI into precision medicine, ensuring these technologies are safe, equitable, and impactful for patients worldwide. Barzilays contributions have earned her numerous honors, including the MacArthur Fellowship, election to the National Academy of Medicine, the National Academy of Engineering and recognition as one of the most influential voices shaping the future of AI in healthcare.